Showing results (2991-3000 of 6,239) with videos related to
Sort By:
Pageof 624
Nature Medicine|March 19, 2025
mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine in healthy adults: a phase 1/2 trialAmanda K Rudman Spergel, Jintanat Ananworanich, Ruiting Guo, et al.Nature Medicine|March 11, 2025
LILRB3 genetic variation is associated with kidney transplant failure in African American recipientsZeguo Sun, Zhengzi Yi, Chengguo Wei, et al.Nature Medicine|March 26, 2025
Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumorsAreeba Patel, Kirsten Göbel, Sebastian Ille, et al.Nature Medicine|March 3, 2025
A first-in-human study of quantitative ultrasound to assess transplant kidney fibrosisEno Hysi, Jihye Baek, Alexander Koven, et al.Nature Medicine|March 7, 2025
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trialJeanne Tie, Yuxuan Wang, Serigne N Lo, et al.Nature Medicine|June 13, 2024
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trialAndrea J Bullock, Benjamin L Schlechter, Marwan G Fakih, et al.Nature Medicine|June 28, 2024
AAV gene therapy for hereditary spastic paraplegia type 50: a phase 1 trial in a single patientJames J Dowling, Terry Pirovolakis, Keshini Devakandan, et al.Nature Medicine|June 5, 2024
Bilateral gene therapy in children with autosomal recessive deafness 9: single-arm trial resultsHui Wang, Yuxin Chen, Jun Lv, et al.Nature Medicine|June 6, 2024
A cost-effectiveness analysis of early detection and bundled treatment of postpartum hemorrhage alongside the E-MOTIVE trialEleanor V Williams, Ilias Goranitis, Raymond Oppong, et al.Nature Medicine|June 1, 2024
Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trialThomas Powles, Yen-Hwa Chang, Yoshiaki Yamamoto, et al.Pageof 624